产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 99% | 询价 | |||
| 25mg | 99% | 询价 | |||
| 50mg | 99% | 询价 | |||
| 100mg | 99% | 询价 | |||
| 250mg | 99% | 询价 |
CAS No. |
2245053-57-8 |
|---|---|
中文名称 |
(S)-1-(5-((2,3-二氢-[1,4]二噁烷并[2,3-b]吡啶-7-基)磺酰基)-3,4,5,6-四氢吡咯并[3,4-c]吡咯-2(1H)-基)-3-羟基-2-苯基丙-1-酮 |
英文名称 |
(S)-1-(5-((2,3-Dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-3-hydroxy-2-phenylpropan-1-one |
别名 |
SCHEMBL20511240 | WHO 11646 | Etavopivat [USAN] | MS-28351 | FT4202 | FT-4202 | CS-0213556 | EX-A6335 | V4E0A9M44Q | (S)-1-(5-((2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-3-hydroxy-2-phenylpropan |
标准英文名 |
(S)-1-(5-((2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-7-yl)sulfonyl)-3,4,5,6-tetrahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)-3-hydroxy-2-phenylpropan-1-one |
MDL No. |
MFCD34578328 |
分子式 |
C22H23N3O6S |
分子量 |
457.51 |
精确分子量 |
457.13 |
SMILES |
O=C(N1CC(CN(S(=O)(C2=CN=C(OCCO3)C3=C2)=O)C4)=C4C1)[C@@H](C5=CC=CC=C5)CO |
标准SMILES |
OC[C@H](C1C=CC=CC=1)C(=O)N1CC2CN(CC=2C1)S(=O)(=O)C1=CN=C2OCCOC2=C1 |
性状 |
White to off-white powder or crystals |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
KZFFYEPYCVDOGE-LJQANCHMSA-N |
危险类别(旧) |
H302,H315,H319 |
存储要求 |
Inert atmosphere, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Skin corrosion/irritation (Category 2),Serious eye damage/eye irritation (Category 2A) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|